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1.1. N-(4-hydroxyphenyl) retinamide derivatives as potential
chemotherapeutic agents for rhabdoid tumours
Rhabdoid tumours (RTs) are rare, mostly incurable pediatric
malignancies that arise in brain, kidneys and soft tissues These tu-
mours arise mainly in children younger than ﬁve years of age, with
a peak incidence of up to three years of age, and are characterised
by the presence of sheets of rhabdoid cells. The tumours also exhi-
bit biallelic deletions and/or mutations in the INI1/hSNF5 gene.
Current therapeutic regimens to treat rhabdoid tumours involve
empirically selected combinations of chemotherapeutic agents that
are toxic and rarely curative, leading to low survival rates. Therefore
there is a great need for novel therapeutics to treat these tumours,
particularly those based on an understanding of molecular factors
responsible for the genesis, growth, and survival of these tumours.
It has been demonstrated previously that Cyclin D1 is essential for
the genesis and survival of rhabdoid tumours and that chemothera-
peutic agents such as N-(4-hydroxyphenyl) retinamide (1), which tar-
get Cyclin D1, are effective in inhibiting the growth of rhabdoid
tumours. N-(4-hydroxyphenyl) retinamide (1) is currently in phase
III clinical trials for many types of cancer. For example, in clinical
studies with pediatric neuroblastoma patients, N-(4-hydroxyphenyl)
retinamide (1) has demonstratedprolonged stabilisationof thedisease.
The clinical studies performed to date thus indicate that N-(4-
hydroxyphenyl) retinamide (1) is a promising anticancer drug. In
order to improve activity as a chemotherapeutic agent against
rhabdoid tumours, analogues of 1 were generated to assess the
series SAR. Recent work has been undertaken to generate small
libraries of synthetic derivatives and screen for their ability to
induce cytotoxicity in vitro in rhabdoid tumour cell lines.1
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Studies were also initiated to determine the compounds’ poten-
tial for conjugation, such as linking to nanoparticles, in order to
facilitate the compounds crossing of the blood brain barrier. Thusdoi:10.1016/j.comche.2008.11.001
E-mail: nterrett@ensemblediscovery.coma series of anilide analogues of 1 were synthesized in small
libraries starting from the carboxylic acid (2), with reaction pro-
ceeding via the acid chloride (3), then anilide bond formation
through reaction with a set of anilines, to give library compounds
of general structure 4. These compounds were assayed against the
rhabdoid tumour cell line MON. A cell survival assay was carried
out testing the effect of compounds and comparing their effect
on MON cells to that of the parent compounds, N-(4-hydroxyphe-
nyl) retinamide (1) and retinoic acid.
From these assays a number of active compounds were
obtained.Oneof themost potent compoundswas5whichpossessed
an IC50 of 3 lM. The SAR provided by this study suggests that the 4-
hydroxy position of N-(4-hydroxyphenyl) retinamide (as in com-
pound 5) is important for activity. There exists the possibility of
using synthetic derivatives retaining activity in cell culture models
to derive clinically important conjugates for radiotherapy, and also
to identify target proteins responsible for mediating N-(4-hydroxy-
phenyl) retinamide activity in rhabdoid tumour cells.1.2. Discovery of an Aurora kinase inhibitor by dynamic combinatorial
chemistry
In recent times the use of fragments for the discovery of leads
has become common practice amongst the medicinal chemistry
community. A potentially useful approach to lead discovery cou-
ples fragment-based lead discovery with dynamic combinatorial
chemistry. Dynamic combinatorial chemistry allows multimeric
compounds to assemble reversibly from constituent reactants.
The assembly should be guided by experimental conditions that
enrich a reaction mixture for molecules with desired characteris-
tics, such as binding to a receptor present within the equilibration
mixture.
A previously reported fragment-based discovery technology
called tethering with extenders, identiﬁes companion fragments
in the presence of a known binding moiety (the extender). A disad-
vantage with this approach has been that the extender must both
irreversibly modify a target cysteine residue and reversibly capture
companion fragments that bind to an adjacent site. This requires
two sequential rounds of protein modiﬁcation which could disrupt
a protein’s structure. Recently disclosed work describes tethering
using dynamic extenders where the irreversible electrophile of
the extender is replaced with a disulphide, thus enabling both
targeted and reversible cysteine modiﬁcation.2
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This methodology combines dynamic combinatorial chemistry
with fragment-based lead discovery in a generally applicable
way, demonstrated against a protein kinase. Kinase inhibitors can
bind at non-conserved adaptive regions away from the active site.
When compounds bind in locations such as these, they typically
demonstrate high speciﬁcity for individual kinases. However, iden-
tifying such speciﬁc compounds has been difﬁcult. These authors
have applied dynamic combinatorial chemistry to identify a frag-
ment that bound in the adaptive pocket of Aurora A, a kinase which
has been shown to have a critical role in regulating mitosis.
The approach commenced with introduction of a cysteine re-
sidue near the ATP binding site through site-directed mutagen-
esis (T217C) of the Aurora A construct. Next, the protein was
screened against a library of around 4500 disulphide-containing
fragments under partially reducing conditions in the presence of
a dynamic extender (6). Added to the extender were two disul-
phide-containing appendages, one of which anchored the exten-
der to the protein in the purine binding site through the
introduced cysteine residue, whilst the other was placed to cap-
ture disulphide-containing fragments. The screening occurred in
pools of approximately 10 fragments where each fragment had
a unique mass, and a number of hits were obtained from this
screening effort. Subsequently, the disulphide between the ex-
tender and the fragment was replaced with a ﬂexible alkyl linker
and the other disulphide was removed from the diaminopyrimi-
dine to generate soluble compounds.
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One of the most potent compounds formed in this way was 7
which inhibited Aurora A with an IC50 of 17 lM. Further work
sought to replace the diaminopyrimidine moiety with a purine
and shortening of the linker by one methylene, which led to the
compound 8 with an IC50 = 2.9 lM. Compound 8 represents a
48 N. K. Terrett / Combinatorial Chemistnew chemotype that is amenable to further optimisation and so
represents a proof of concept for this technology in its ability to
rapidly identify ligands that could serve as starting points for a
medicinal chemistry program.
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82. A summary of the papers in this month’s issue
2.1. Solid-phase synthesis
A novel, ethylene glycol-based protecting group has been de-
signed and synthesised for use in solid phase peptide synthesis.
Both ether and ester type protected amino acids have been pre-
pared, and the acid stability of the new protecting group showed
complete Fmoc/t-Bu compatibility.3
A new class of isotope-coded afﬁnity tag possessing a ﬂuores-
cent feature, referred to as a ﬂuorescent isotope-coded afﬁnity
tag (FCAT), has been proposed to provide a new tool for quantita-
tive proteomics. The label is designed to bind cysteine containing
proteins or peptides. The ﬂuorescent part of the tag is also planned
to be utilised to isolate the FCAT-labeled peptides via antibody
based pull-down methods. In this recent paper, the solid phase or-
ganic synthesis of the light isotope containing FCAT molecule is
reported.42.2. Solution-phase synthesis
DNA-encoded chemical libraries are increasingly being em-
ployed for the identiﬁcation of molecules binding to protein targets
of pharmaceutical relevance. The synthesis and characterisation of
a DNA-encoded chemical library, consisting of 4000 compounds
generated by Diels-Alder cycloaddition reactions has been
described.5
2.3. Scaffolds and synthons for combinatorial libraries
No papers this month.
2.4. Solid-phase supported reagents
The enantioselectivity for the reduction of ketones by Geotri-
chum candidum NBRC 5767 was improved upon immobilisation
of the whole cell onto an ion exchange resin with polyallylamine.
Furthermore, immobilisation of the cell enhanced the stability of
the enzyme and enabled a continuous-ﬂow reaction under normal
aqueous conditions.6
2.5. Novel resins, linkers and techniques
A new strategy to improve the stereoselectivity in enamine cat-
alysis, by the introduction of super-hydrophobic long-chain sili-
cone/polysiloxane as support/functional group for a model aldol
reaction, has been developed. The homogeneous direct aldol reac-
tion of cyclic ketones with different aromatic aldehydes catalysed
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high yields, good diastereoselectivity and up to 99% ee.7
A series of novel polystyrene-oligo(oxyethylene) graft copoly-
mers containing monodisperse PEG units (n = 2–12) have been
synthesised and examined for their applicability in gel-phase 13C
NMR spectroscopy. A strong correlation between the graft length
and the line widths in the gel-phase spectra was observed. By
grafting a PEG chain with only eight units, it was possible to obtain
results similar to TentaGel resin.8
Molecular discovery often involves identiﬁcation of the best
functional groups (substituents) on a scaffold. When multiple sub-
stitution sites are present, the number of possible substituent com-
binations can be very large. A recent article introduces a strategy
for efﬁciently optimising the substituent combinations by iterative
rounds of compound sampling, substituent reordering to produce
the most regular property landscape, and property estimation over
the landscape.9
Carbohydrate biosensors, including carbohydrate arrays, are
attracting increased attention for the comprehensive and high-
throughput investigation of protein–carbohydrate interactions.
An effective approach to fabricating a robust microplate-based
carbohydrate array capable of probing protein binding and
screening for inhibitors in a high-throughout manner has been
developed. This approach involves the derivatisation of carbohy-
drates with a trityl group through an alkyl linker and the immo-
bilisation of the trityl-derivatised carbohydrates (mannose and
maltose) onto microplates noncovalently to construct carbohy-
drate arrays.10
2.6. Library applications
A facile and efﬁcient preparation of pyrazoloquinolin-4-ones, as
potential ligands for the estrogen receptor, via a PIFA [phenyliodi-
ne(III)bis(triﬂuoroacetate)]-promoted cyclisation reaction has
been described. The strategy, based on an electrophilic amidation
reaction as the key step of the synthesis, allows the generation of
a diverse array of derivatives.11
A novel set of activity-based probes (ABPs) for functionally pro-
ﬁling metallo-aminopeptidases has been synthesised based on the
bestatin inhibitor scaffold, using solid-phase techniques. These
ABPs were shown to label metallo-aminopeptidases, using both a
biotin and a ﬂuorophore reporter, in an activity-dependent man-
ner. This probe class was also shown to be amenable to ‘click’
chemistry labeling for possible use in live cells.12
Lactimidomycin (LTM), iso-migrastatin (iso-MGS) and migras-
tatin (MGS) are macrolide antitumour antibiotics differing in
macrolide ring size but all bearing a glutarimide side chain. A re-
cent paper describes the production and evaluation of the biologi-
cal activities of a small library of iso-MGS and LTM-derived agents.
Congeners evaluated bear either the MGS scaffold or related acyclic
(dorrigocin) scaffolds. Scratch wound-healing assays with 4T1
mouse and MDA-MB-231 human mammary tumour cell lines re-
veal structural elements crucial to inhibition of cell migration by
these compounds.13
A focused library of TX-67 (C10 hemi-succinate) analogues has
been prepared, including C7 regioisomers, esters, amides, and one-
carbon homologues. These were prepared to investigate whether
the lack of TX-67 interaction with P-glycoprotein (Pgp) is due to
the presence of the carboxylic acid moiety and whether this phe-
nomenon was restricted to C10 analogs. Tubulin stabilisation abil-
ity, cytotoxicity, and Pgp interactions were all evaluated.14
A focused library of N-aryl l-homoserine lactones was designed
around known lactone leads and evaluated for antagonistic and
agonistic activity against quorum-sensing receptors in Agrobacter-
ium tumefaciens, Pseudomonas aeruginosa, and Vibrio ﬁscheri. Sev-
eral compounds were identiﬁed with signiﬁcantly heightenedactivities relative to the lead compounds, and new structure–activ-
ity relationships (SARs) were delineated.15
Creutzfeldt–Jakob disease (CJD) is associated with an abnor-
mally folded prion protein, PrP-res, which is thought to form due
to interactions between normal prion PrPC and PrP-res. Small pep-
tides have been designed to prevent this interaction, and a struc-
ture–activity relationship has been described for a series of
peptides which were synthesised and tested for their activity
against two prion disease model assays. New libraries were
synthesised in order to discover new, shorter peptides which could
be leads for developing peptidomimetics.16
The synthesis and SAR for a series of diaminopyrimidines as
PYK2 inhibitors have been described. Using a combination of li-
brary and traditional medicinal chemistry techniques, a FAK-selec-
tive chemical series was transformed into compounds possessing
good PYK2 potency and 10- to 20-fold selectivity against FAK.17
Hepatitis C virus (HCV) NS5B RNA polymerase is crucial for re-
plicating the HCV RNA genome and is an attractive target for devel-
oping anti-HCV drugs. A novel series of 2,3-diaryl-1,3-thiazolidin-
4-one derivatives were evaluated for their ability to inhibit HCV
NS5B, and for this series, several compounds displayed over 95%
inhibition of NS5B RNA polymerase activity in vitro.18
A series of dihydroxylphenyl amides have been discovered as
Hsp90 inhibitors based on a HTS hit using structure based design
and library synthesis techniques. Information from X-ray crystal
structures were used to optimise the potency of a HTS hit in a
Hsp90 competitive binding assay. Two enantio-pure compounds
were potent in PGA-based competitive binding assay and inhibited
proliferation of various human cancer cell lines in vitro, with IC50
values averaging 20 nM.19
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